BF-B

Brown-Forman Corporation

$26.80

+0.98%
Apr 8, 2026
Bobby Quantitative Model
Brown-Forman Corporation is a leading global producer and marketer of premium alcoholic beverages, operating in the Wineries & Distilleries industry within the Consumer Defensive sector. The company is distinguished by its iconic, brand-driven portfolio, most notably the global powerhouse Jack Daniel's Tennessee Whiskey, which anchors its identity as a premium spirits leader with a deep heritage and significant pricing power. The current investor narrative is focused on the company's ability to navigate a challenging macroeconomic environment for consumer staples, with recent quarterly results showing modest revenue growth but significant margin pressure, leading to debates about its valuation premium and the sustainability of its earnings trajectory in the face of potential consumer downtrading.

People also watch

Constellation Brands, Inc.

Constellation Brands, Inc.

STZ

Analysis
Walmart Inc. Common Stock

Walmart Inc. Common Stock

WMT

Analysis
Costco Wholesale Corp

Costco Wholesale Corp

COST

Analysis
Coca-Cola Company

Coca-Cola Company

KO

Analysis
Procter & Gamble Company

Procter & Gamble Company

PG

Analysis

BF-B 12-Month Price Forecast

Historical Price
Current Price $26.805
Average Target $26.805
High Target $30.825749999999996
Low Target $22.78425

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Brown-Forman Corporation's 12-month outlook, with a consensus price target around $34.85 and implied upside of +30.0% versus the current price.

Average Target

$34.85

16 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

16

covering this stock

Price Range

$21 - $35

Analyst target range

Buy
4 (25%)
Hold
8 (50%)
Sell
4 (25%)

The stock is covered by 16 analysts, indicating substantial institutional interest. The consensus sentiment appears neutral to cautious, as evidenced by recent rating actions from major firms like Citigroup and JP Morgan moving to Neutral from Sell and Underweight, respectively, though Barclays maintains an Overweight rating. The average target price and specific Buy/Hold/Sell distribution are not provided in the data, preventing a calculation of implied upside or downside to consensus. The target price range is also not available, but the recent pattern of institutional ratings shows a shift towards neutrality in March 2026, suggesting analysts are waiting for clearer signs of fundamental improvement before turning more bullish; the lack of a defined target range in the data points to potential uncertainty or divergence in analyst views on the stock's fair value.

Drowning in data?

Find the real signal!

Bulls vs Bears: BF-B Investment Factors

The evidence currently tilts bearish, as the stock's persistent downtrend, decelerating revenue growth, and margin pressures outweigh its strong fundamentals and valuation discount. The most critical tension in the investment debate is whether Brown-Forman's premium brand pricing power and fortress balance sheet can successfully navigate a prolonged period of consumer weakness, or if the current low-single-digit growth represents a new, lower normal that justifies a permanent de-rating from its historical valuation premium. The resolution of this tension—specifically, the trajectory of revenue growth and gross margins over the next few quarters—will determine the direction of the stock.

Bullish

  • Strong Balance Sheet & Cash Flow: The company boasts a fortress balance sheet with a current ratio of 3.88 and a manageable debt-to-equity of 0.68. It generated $730 million in TTM free cash flow, providing ample liquidity for dividends, buybacks, and investments without financial stress.
  • Trading at Historical Valuation Discount: The stock's trailing P/E of 18.95x is well below its historical peaks above 35x, indicating a significant discount to its own long-term valuation. The forward P/E of 15.74x further suggests the market has already priced in near-term earnings pressure.
  • Defensive Profile with Low Beta: With a beta of 0.421, BF-B exhibits low volatility and defensive characteristics, providing downside cushion during market downturns. This was evidenced by its -19.9% 1-year decline significantly outperforming the S&P 500's +22.2% gain on a relative basis.
  • High Profitability & Premium Margins: The company maintains robust profitability with a Q3 gross margin of 60.87% and a net margin of 25.1%. Despite recent pressure, these high-margin levels demonstrate the pricing power and premium nature of its brand portfolio.

Bearish

  • Persistent Revenue Growth Deceleration: Q3 revenue grew only 2.71% YoY, a significant slowdown from prior-year performance. Sequential quarterly revenue has been volatile ($924M to $1.041B to $1.063B), indicating a lack of consistent top-line momentum in a challenging consumer environment.
  • Technical Downtrend Near 52-Week Lows: The stock is down 19.89% over the past year and trades just 26% above its 52-week low of $22.61, having failed to sustain a recovery. Recent momentum shows the short-term bounce has stalled, with the stock down 4.03% over the past month.
  • Margin Compression Pressures Earnings: While gross margin improved slightly in Q3 to 60.87% from 59.84% a year ago, operating margins have faced pressure. This margin squeeze, combined with modest revenue growth, has led to earnings volatility and questions about the sustainability of profit growth.
  • Heavy Reliance on Jack Daniel's Brand: The Whiskey segment, dominated by Jack Daniel's, generated $797M of the $1.063B Q3 revenue, representing approximately 75% concentration. This creates significant single-brand risk if consumer preferences shift or if the brand faces competitive or regulatory challenges.

BF-B Technical Analysis

The stock is in a pronounced downtrend, having declined 19.89% over the past year, and is currently trading near the lower end of its 52-week range, approximately 26% above its 52-week low of $22.61 and 26% below its 52-week high of $36.18. This positioning near recent lows suggests the stock is in a value-seeking or capitulation phase, having failed to sustain a recovery attempt from its March 2026 lows. Recent momentum shows a stark divergence: while the stock is up 3.28% over the last three months, it is down 4.03% over the past month, indicating the short-term recovery from the March sell-off has stalled, and the dominant longer-term downtrend is reasserting itself. The stock's beta of 0.421 confirms its defensive, low-volatility characteristics relative to the broader market, which has provided some downside cushion but also limits its upside participation during market rallies. Key technical support is firmly established at the 52-week low of $22.61, while resistance lies at the recent recovery high near $30.39 from February; a sustained break below support would signal a continuation of the bear trend, while a move above $30.39 is needed to suggest a more durable reversal is underway.

Beta

0.42

0.42x market volatility

Max Drawdown

-52.7%

Largest decline past year

52-Week Range

$23-$36

Price range past year

Annual Return

-11.9%

Cumulative gain past year

PeriodBF-B ReturnS&P 500
1m+7.8%-2.8%
3m+5.3%-4.4%
6m+2.1%+0.9%
1y-11.9%+32.8%
ytd+3.5%-3.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

BF-B Fundamental Analysis

Revenue growth has been modest but positive, with the most recent Q3 FY2026 revenue of $1.063 billion representing a 2.71% year-over-year increase; however, this marks a deceleration from the prior year's Q3, and sequential quarterly revenue has shown volatility, growing from $924M in Q1 to $1.041B in Q2 before the latest figure. The Whiskey segment, led by Jack Daniel's, remains the dominant driver with $797 million in revenue, while Ready-to-Drink products contributed $146 million, indicating diversification beyond the core. The company is highly profitable, with Q3 net income of $267 million and a robust gross margin of 60.87%, though this represents a slight compression from the 59.84% gross margin in the prior-year quarter, and operating margins have also come under pressure. The balance sheet is exceptionally strong, featuring a high current ratio of 3.88 and a manageable debt-to-equity ratio of 0.68, while the company generated substantial free cash flow of $730 million over the trailing twelve months, providing ample liquidity for dividends, share repurchases, and organic investment without reliance on external financing.

Quarterly Revenue

$1.1B

2026-01

Revenue YoY Growth

+0.02%

YoY Comparison

Gross Margin

+0.60%

Latest Quarter

Free Cash Flow

$730000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Open an Account, get $2 TSLA now!

Valuation Analysis: Is BF-B Overvalued?

Given the company's consistent profitability with net income of $267 million, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 18.95x and a forward PE of 15.74x based on estimated EPS; the forward multiple's discount to the trailing figure implies the market expects earnings growth to resume after a period of compression. Compared to sector averages, Brown-Forman's valuation presents a mixed picture: its trailing PE of 18.95x is below the typical premium it has historically commanded, while its Price-to-Sales ratio of 4.14x and EV/EBITDA of 14.54x need to be contextualized against peers, though specific industry averages are not provided in the data. Historically, the current trailing PE of 18.95x sits well below its own multi-year range, which has seen peaks above 35x; this suggests the stock is trading at a discount to its own historical valuation, which could indicate a value opportunity if fundamentals stabilize, or it may reflect a market reassessment of its long-term growth profile.

PE

18.9x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 12x~80x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

14.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks center on revenue concentration and margin sustainability. Approximately 75% of Q3 revenue came from the Whiskey segment, primarily Jack Daniel's, creating significant single-brand dependency. While gross margins remain high at 60.87%, they have shown volatility, and any sustained compression would directly pressure the bottom line given the company's high fixed-cost structure. The modest 2.71% YoY revenue growth raises questions about whether the company can grow into its current valuation multiples, particularly its PS ratio of 4.14x and EV/EBITDA of 14.54x.

Market & Competitive Risks are heightened by the stock's valuation premium relative to its growth rate, creating multiple compression risk if the 'growth at a reasonable price' narrative falters. The low beta of 0.421, while defensive, also limits upside participation during broad market rallies. Competitive pressures in the global spirits market and potential consumer downtrading from premium brands in a weaker macroeconomic environment pose external threats. The stock's 42.1% underperformance relative to the S&P 500 over the past year suggests it is already facing a severe sector rotation away from premium consumer staples.

The Worst-Case Scenario involves a deepening consumer recession leading to significant volume declines for Jack Daniel's, combined with increased promotional spending that crushes gross margins below 55%. This could trigger analyst downgrades and a re-rating to a P/E in the low teens, aligning with the bearish end of historical ranges. The realistic downside from the current price of $26.75 is approximately -15% to the 52-week low of $22.61, but a breach of that level could see the stock test the $20 support, representing a potential loss of -25% or more in an adverse scenario.